Advanced Human Imaging - General Discussion, page-251

I hear you, the imminent is interesting. Which will be a 4c or and half yearly. The costs versus the revenue flowing. Should Tinjoy produce revenue by then? It’s interesting for sure. That falls over = costs.
A sell? an excited quote based on market activity. Huge volume, red candle upon opening after a lengthy TH doesn’t say we are building a base at ex price.

I just unfortunately see massive costs and SH dilution whilst we establish ourselves. Will that acquisition work long term in our favour? Yes. Shortterm possibly no. Too much spending.